Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1998 2
2002 1
2003 2
2005 7
2006 9
2007 7
2008 8
2009 7
2010 1
2011 3
2012 5
2013 3
2014 2
2015 3
2017 3
2018 4
2019 1
2020 1
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Results by year
Filters applied: . Clear all
Page 1
Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
Floris G, Richard F, Hamy AS, Jongen L, Wildiers H, Ardui J, Punie K, Smeets A, Berteloot P, Vergote I, De Croze D, Meseure D, Salomon A, Laé M, Reyal F, Biganzoli E, Neven P, Desmedt C. Floris G, et al. Among authors: berteloot p. J Natl Cancer Inst. 2021 Feb 1;113(2):146-153. doi: 10.1093/jnci/djaa090. J Natl Cancer Inst. 2021. PMID: 33152071 Free PMC article.
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort.
Thijssen S, Wildiers H, Punie K, Beuselinck B, Clement P, Remmerie C, Berteloot P, Han S, Van Nieuwenhuysen E, Van Gorp T, Vergote I, Smeets A, Nevelsteen I, Floris G, Weltens C, Menten J, Janssen H, Laenen A, Neven P. Thijssen S, et al. Among authors: berteloot p. J Cancer Res Clin Oncol. 2021 Apr;147(4):1041-1048. doi: 10.1007/s00432-020-03487-1. Epub 2021 Jan 20. J Cancer Res Clin Oncol. 2021. PMID: 33471187 Clinical Trial.
Neoadjuvant chemotherapy for ovarian cancer.
Vergote I, van Gorp T, Amant F, Neven P, Berteloot P. Vergote I, et al. Among authors: berteloot p. Oncology (Williston Park). 2005 Nov;19(12):1615-22; discussion 1623-30. Oncology (Williston Park). 2005. PMID: 16396153 Free article. Review.
Timing of debulking surgery in advanced ovarian cancer.
Vergote I, van Gorp T, Amant F, Leunen K, Neven P, Berteloot P. Vergote I, et al. Among authors: berteloot p. Int J Gynecol Cancer. 2008 Mar-Apr;18 Suppl 1:11-9. doi: 10.1111/j.1525-1438.2007.01098.x. Int J Gynecol Cancer. 2008. PMID: 18336393 Review.
Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancer.
Hoste G, Punie K, Wildiers H, Beuselinck B, Lefever I, Van Nieuwenhuysen E, Han SN, Berteloot P, Concin N, Salihi R, Vergote I, Neven P. Hoste G, et al. Among authors: berteloot p. Breast Cancer Res Treat. 2018 Aug;171(1):131-141. doi: 10.1007/s10549-018-4827-6. Epub 2018 May 16. Breast Cancer Res Treat. 2018. PMID: 29766363
Cause of death for patients with breast cancer: discordance between death certificates and medical files, and impact on survival estimates.
Izci H, Tambuyzer T, Vandeven J, Xicluna J, Wildiers H, Punie K, Willers N, Oldenburger E, Van Nieuwenhuysen E, Berteloot P, Smeets A, Nevelsteen I, Deblander A, De Schutter H, Neven P, Silversmit G, Verdoodt F. Izci H, et al. Among authors: berteloot p. Arch Public Health. 2021 Jun 23;79(1):111. doi: 10.1186/s13690-021-00637-w. Arch Public Health. 2021. PMID: 34162431 Free PMC article.
64 results